HIGHLIGHTS
- who: Francesca Schiano di Cola from the Clinical and Experimental Sciences Department, Neurology Unit, University and SpedaliCivili, Brescia, Italy have published the paper: CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients, in the Journal: (JOURNAL) of 26/05/2022
- future: Studies will be needed to evaluate whether disease duration or the number of previously failed prophylaxes might actually have an effect on the overall clinical response in patients treated with CGRPmonoclonal_antibodies.
SUMMARY
Patients` data regarding migraine history, clinical and demographical information, previous and current acute and preventive migraine treatments . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.